Oral Campylobacter species: Initiators of a subgroup of inflammatory bowel disease?

Li Zhang
Author Information
  1. Li Zhang: Li Zhang, School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.

Abstract

In recent years, a number of studies detected a significantly higher prevalence of Campylobacter species such as Campylobacter concisus (C. concisus) in intestinal biopsies and fecal samples collected from patients with inflammatory bowel disease (IBD) compared to controls. Most of these Campylobacter species are not of zoonotic origin but are human oral Campylobacter species. Bacterial species usually cause diseases in the location where they colonize. However, C. concisus and other oral Campylobacter species are associated with IBD occurring at the lower parts of the gastrointestinal tract, suggesting that these Campylobacter species may have unique virulence factors that are expressed in the lower parts of the gastrointestinal tract.

Keywords

References

  1. Clin Microbiol Infect. 2013 May;19(5):445-50 [PMID: 22512739]
  2. J Med Microbiol. 2015 Apr;64(Pt 4):438-445 [PMID: 25657299]
  3. Inflamm Bowel Dis. 2010 Jun;16(6):1008-16 [PMID: 19885905]
  4. J Med Microbiol. 1989 May;29(1):63-73 [PMID: 2724326]
  5. PLoS One. 2013 Aug 30;8(8):e71515 [PMID: 24023611]
  6. Lancet. 1991 Sep 28;338(8770):771-4 [PMID: 1681159]
  7. PLoS One. 2013 Sep 23;8(9):e75525 [PMID: 24086553]
  8. J Clin Microbiol. 2000 Jan;38(1):286-91 [PMID: 10618103]
  9. PLoS One. 2011;6(9):e25417 [PMID: 21966525]
  10. N Engl J Med. 2002 Aug 8;347(6):417-29 [PMID: 12167685]
  11. Infect Immun. 1998 May;66(5):1928-33 [PMID: 9573071]
  12. Q J Med. 1992 Feb;82(298):125-38 [PMID: 1620813]
  13. J Clin Microbiol. 2010 Aug;48(8):2965-7 [PMID: 20519479]
  14. World J Gastroenterol. 2014 Feb 7;20(5):1192-210 [PMID: 24574795]
  15. Eur J Gastroenterol Hepatol. 1999 May;11(5):543-6 [PMID: 10755259]
  16. PLoS One. 2012;7(7):e41594 [PMID: 22848538]
  17. Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):390-407 [PMID: 16819502]
  18. PLoS One. 2011;6(6):e21490 [PMID: 21738679]
  19. Int J Microbiol. 2014;2014:476047 [PMID: 25214843]
  20. BMC Microbiol. 2011 Jan 10;11:7 [PMID: 21219646]
  21. J Clin Microbiol. 2009 Feb;47(2):453-5 [PMID: 19052183]
  22. Clin Microbiol Rev. 1996 Jan;9(1):18-33 [PMID: 8665474]
  23. Science. 2013 Feb 8;339(6120):708-11 [PMID: 23393266]
  24. World J Gastroenterol. 2014 Feb 7;20(5):1259-67 [PMID: 24574800]
  25. J Dent Res. 2000 Feb;79(2):785-92 [PMID: 10728981]
  26. Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30 [PMID: 22001864]
  27. Prog Mol Biol Transl Sci. 2012;105:263-320 [PMID: 22137435]
  28. Cell Host Microbe. 2014 Mar 12;15(3):382-392 [PMID: 24629344]
  29. PLoS One. 2013;8(3):e58825 [PMID: 23554935]

MeSH Term

Anti-Bacterial Agents
Campylobacter
Campylobacter Infections
Colitis, Ulcerative
Crohn Disease
Host-Pathogen Interactions
Humans
Intestines
Mouth
Risk Factors
Virulence

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0CampylobacterspeciesconcisusboweldiseaseCinflammatoryIBDorallowerpartsgastrointestinaltractOralrecentyearsnumberstudiesdetectedsignificantlyhigherprevalenceintestinalbiopsiesfecalsamplescollectedpatientscomparedcontrolszoonoticoriginhumanBacterialusuallycausediseaseslocationcolonizeHoweverassociatedoccurringsuggestingmayuniquevirulencefactorsexpressedspecies:Initiatorssubgroupdisease?CampylobacterCrohn’sInflammatoryUlcerativecolitis

Similar Articles

Cited By (17)